Using a stem cell-derived therapeutic developed over more than a decade in Dr. David Gamm’s lab at UW-Madison, BlueRock Therapeutics has treated the first patient in a new Phase 1/2a clinical trial aimed at a group of …
Month: July 2025
Dr. Karen Schloss featured on Wisconsin Public Radio
MERI member Karen Schloss (UW Department of Psychology and Wisconsin Institute for Discovery), recently sat down with WPR’s The Larry Meiller Show to discuss her research on how colors influence meaning, behavior, and emotion. Listen …
Researchers find the tipping point at which compensatory measures in a diseased retinal circuit shift from beneficial to detrimental
A recent study by the Hoon lab published in Current Biology has uncovered new modes of retinal circuit compensation and adaptation in response to impairments seen in congenital stationary night blindness (CSNB). CSNB is a retinal disease …